Marginalised Bristol groups offered tailored health advice
People from ethnic minority and marginalised community groups are being offered advice on health issues that disproportionately affect them. The Bristol Community Health Day on
People from ethnic minority and marginalised community groups are being offered advice on health issues that disproportionately affect them. The Bristol Community Health Day on
The US Food and Drug Administration (FDA) has approved Mounjaro (tirzepatide), Eli Lilly and Company’s new once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1)
Diabeloop has developed an algorithm that is hosted on a dedicated handset and serves as a bridge between continuous glucose monitors and insulin pumps. Every
Bariatric surgery has become more common as global rates of obesity have increased, but it may also raise the risk of developing epilepsy, according to
According to a study published in Diabetes Technology & Therapeutics, while closed-loop insulin delivery systems can increase glucose time in range and reduce hypoglycemia episodes
NHS England patients with Type 1 diabetes will now be eligible for life-changing continuous glucose monitors after the health service secured a new cut-price deal.
Diabetes costs the NHS around £10bn a year. It is a national priority and a focus of the NHS Long Term Plan. There are guidelines
Verily’s Onduo has announced that it has entered into a strategic collaboration with Sword Health to broaden virtual care for diabetes and other conditions, as
A recent research study has found that childhood obesity is more common now than 12 years ago – which is particularly troubling news, given that
A new study has found that Vitamin D deficiency has a causative role in the systemic inflammation that commonly accompanies it, with inflammation declining as